carbamates has been researched along with dasatinib in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Axelrod, MJ; Capaldo, B; Conaway, M; Gioeli, DG; Jameson, MJ; Khalil, A; Leimgruber, SS; Mendez, RE; Sharlow, ER; Weber, MJ | 1 |
1 other study(ies) available for carbamates and dasatinib
Article | Year |
---|---|
Synergistic apoptosis in head and neck squamous cell carcinoma cells by co-inhibition of insulin-like growth factor-1 receptor signaling and compensatory signaling pathways.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carbamates; Carcinoma, Squamous Cell; Cell Culture Techniques; Cell Line, Tumor; Dasatinib; Drug Resistance, Neoplasm; Drug Synergism; Head and Neck Neoplasms; Humans; Phosphorylation; Proto-Oncogene Proteins c-akt; Pyrazoles; Receptor, IGF Type 1; Signal Transduction; Triazines | 2015 |